This effect was confirmed by a previous report, which indicated that the treatment of HCV-infected type 2 diabetic (T2DM) patients with the antiviral Sofosbuvir/ledipasvir results in symptomatic hypoglycemia despite the decrease in insulin dosage [11]. Here, INS is linked to type 2 diabetes mellitus.